Clinical Trial Update: Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife® [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of CartiLife for articular cartilage lesions of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Lesion of the Knee

Drugs mentioned

• CartiLife

Snippet

Sponsor: Biosolution Co., Ltd. | Conditions: Articular Cartilage Lesion of the Knee | Phase 2 | Status: COMPLETED